Towards shedding some light on regorafenib treatment in refractory metastatic colorectal cancer

被引：1
作者：
Prager, Gerald [1 ]
Argiles, Guillem [2 ]
机构：
[1] Med Univ Vienna, Dept Med 1, Vienna, Austria
[2] Vall d Hebron Univ Hosp, VHIO, Barcelona, Spain
来源：
ESMO OPEN | 2017年 / 2卷 / 03期
关键词：
RANDOMIZED PHASE-III; DOUBLE-BLIND; 1ST-LINE TREATMENT; BEVACIZUMAB; FLUOROURACIL; OXALIPLATIN; LEUCOVORIN; PLACEBO; TRIAL; COMBINATION;
D O I：
10.1136/esmoopen-2017-000205
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 20 条
  • [1] [Anonymous], ASCO M S
  • [2] Bendell CT JC, 2011, J CLIN ONCOL, P29
  • [3] Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial
    Bennouna, Jaafar
    Sastre, Javier
    Arnold, Dirk
    Osterlund, Pia
    Greil, Richard
    Van Cutsem, Eric
    von Moos, Roger
    Maria Vieitez, Jose
    Bouche, Olivier
    Borg, Christophe
    Steffens, Claus-Christoph
    Alonso-Orduna, Vicente
    Schlichting, Christoph
    Reyes-Rivera, Irmarie
    Bendahmane, Belguendouz
    Andre, Thierry
    Kubicka, Stefan
    [J]. LANCET ONCOLOGY, 2013, 14 (01) : 29 - 37
  • [4] Fluorouracil, Leucovorin, and Irinotecan Plus Either Sunitinib or Placebo in Metastatic Colorectal Cancer: A Randomized, Phase III Trial
    Carrato, Alfredo
    Swieboda-Sadlej, Anna
    Staszewska-Skurczynska, Marzanna
    Lim, Robert
    Roman, Laslo
    Shparyk, Yaroslav
    Bondarenko, Igor
    Jonker, Derek J.
    Sun, Yan
    De la Cruz, Jhony A.
    Williams, J. Andrew
    Korytowsky, Beata
    Christensen, James G.
    Lin, Xun
    Tursi, Jennifer M.
    Lechuga, Maria J.
    Van Cutsem, Eric
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (10) : 1341 - 1347
  • [5] Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: Results from the Eastern Cooperative Oncology Group Study E3200
    Giantonio, Bruce J.
    Catalano, Paul J.
    Meropol, Neal J.
    O'Dwyer, Peter J.
    Mitchell, Edith P.
    Alberts, Steven R.
    Schwartz, Michael A.
    Benson, Al B., III
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (12) : 1539 - 1544
  • [6] Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
    Grothey, Axel
    Van Cutsem, Eric
    Sobrero, Alberto
    Siena, Salvatore
    Falcone, Alfredo
    Ychou, Marc
    Humblet, Yves
    Bouche, Olivier
    Mineur, Laurent
    Barone, Carlo
    Adenis, Antoine
    Tabernero, Josep
    Yoshino, Takayuki
    Lenz, Heinz-Josef
    Goldberg, Richard M.
    Sargent, Daniel J.
    Cihon, Frank
    Cupit, Lisa
    Wagner, Andrea
    Laurent, Dirk
    [J]. LANCET, 2013, 381 (9863) : 303 - 312
  • [7] Heinz-Josef Lenz EVC, 2013, J CLIN ONCOL, V31, P3514
  • [8] Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
    Hurwitz, H
    Fehrenbacher, L
    Novotny, W
    Cartwright, T
    Hainsworth, J
    Heim, W
    Berlin, J
    Baron, A
    Griffing, S
    Holmgren, E
    Ferrara, N
    Fyfe, G
    Rogers, B
    Ross, R
    Kabbinavar, F
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (23) : 2335 - 2342
  • [9] Michael Teufel SS, 2015, J CLIN ONCOL, P33
  • [10] Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer:: A randomized phase III study
    Saltz, Leonard B.
    Clarke, Stephen
    Diaz-Rubio, Eduardo
    Scheithauer, Werner
    Figer, Arie
    Wong, Ralph
    Koski, Sheryl
    Lichinitser, Mikhail
    Yang, Tsai-Shen
    Rivera, Fernando
    Couture, Felix
    Sirzen, Florin
    Cassidy, Jim
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (12) : 2013 - 2019
12